Compare LLY & WMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LLY | WMT |
|---|---|---|
| Founded | 1876 | 1945 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Department/Specialty Retail Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 948.5B | 817.1B |
| IPO Year | N/A | 1970 |
| Metric | LLY | WMT |
|---|---|---|
| Price | $1,008.13 | $115.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 18 | 30 |
| Target Price | ★ $1,063.44 | $118.27 |
| AVG Volume (30 Days) | 3.9M | ★ 22.2M |
| Earning Date | 10-30-2025 | 11-20-2025 |
| Dividend Yield | 0.59% | ★ 0.82% |
| EPS Growth | ★ 121.02 | 18.15 |
| EPS | ★ 20.44 | 2.86 |
| Revenue | $59,419,800,000.00 | ★ $703,061,000,000.00 |
| Revenue This Year | $42.59 | $5.70 |
| Revenue Next Year | $19.62 | $4.91 |
| P/E Ratio | $49.42 | ★ $40.25 |
| Revenue Growth | ★ 45.41 | 4.34 |
| 52 Week Low | $623.78 | $79.81 |
| 52 Week High | $1,111.99 | $116.27 |
| Indicator | LLY | WMT |
|---|---|---|
| Relative Strength Index (RSI) | 53.32 | 72.71 |
| Support Level | $1,038.00 | $103.76 |
| Resistance Level | $1,111.99 | $114.89 |
| Average True Range (ATR) | 27.26 | 2.35 |
| MACD | -13.38 | 1.13 |
| Stochastic Oscillator | 8.00 | 91.83 |
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Since its founding in 1962, Walmart has become the world's largest retailer, operating over 10,700 stores globally (including 4,600 namesake locations on its home turf and another 600 Sam's Club outlets) and growing its e-commerce presence, attracting 270 million customers weekly. In aggregate, the firm posted more than $680 billion in fiscal 2025 sales. Its core operations span three reporting segments: Walmart US (68% of fiscal 2025 sales), Walmart International (18%), and Sam's Club (14%). Within the US, nearly 60% of its $465 billion in fiscal 2025 revenue came from its grocery offerings, with another quarter from general merchandise. Internationally, Walmart's operations are concentrated in Mexico, though it also has budding exposure to India.